Advertisements

Pivotal Therapeutics Inc. (PVO:CNX) Stock Quote

Detailed Quote for Pivotal Therapeutics Inc. (PVO:CNX)
$ 0.03 0.00 (0.00%) Volume: 30k 9:54 AM EDT Apr 28, 2016
Today 5d 1m 3m 1y more
Last Price
0.03
Change $
Change %
Tick
  
Bid
0.02
Bid Size
18,000
Ask
0.03
Ask Size
150,000
Open
0.03
High
0.03
Low
0.03
Prev Close
0.03
Last Trade
04/28/16
Volume
30k
52 Wk Hi
0.14
52 Wk Low
0.015
Market Cap
2.9m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
96,566,669
EPS (TTM)
-0.04
PE Ratio
N/A
Exchange
CSE
News and Media for Pivotal Therapeutics Inc. (PVO:CNX)
Sector News | Topic News
News for Pivotal Therapeutics Inc. (PVO:CNX)
Fri, Mar 04, 2016
2:45 PM IIROC Trade Resumption - PVO - Canada Newswire
2:23 PM Pivotal Therapeutics Announces Update on Outstanding Convertible Notes and Possible Petition into Bankruptcy - TheNewsWire
2:12 PM IIROC Trading Halt - PVO - Canada Newswire
Tue, Feb 02, 2016
5:36 PM Pivotal Therapeutics Announces Issuance of US Patent 9,248,138 for the Stabilization of Vulnerable Plaque Utilizing a Combination of Statin and Omega 3 Fatty Acids - TheNewsWire
Mon, Jan 04, 2016
9:28 PM Pivotal Therapeutics Announces Payment of Interest on Outstanding Convertible Notes - TheNewsWire
Mon, Nov 30, 2015
12:43 PM Pivotal Therapeutics Announces Third Quarter Financial Results and Executes Distribution Agreement - TheNewsWire
Fri, Nov 27, 2015
5:55 PM Pivotal Therapeutics Closes First Tranche of Equity Financing - TheNewsWire
Wed, Nov 25, 2015
5:45 PM BeneFishial(TM) Pet Formulation Approved For Sale - The First in Pivotal's Animal Health and Nutrition Line - TheNewsWire
Fri, Nov 06, 2015
3:12 PM Pivotal Announces Publication Evaluating 171 Over-the-Counter (OTC) Omega-3 Nutritional Supplements - 50% of the OTC Products Failed at Least one of the Oxidative Safety Limits - TheNewsWire
Thu, Nov 05, 2015
5:04 PM Pivotal Therapeutics Announces Proposed Equity Financing - TheNewsWire
Thu, Oct 08, 2015
3:36 PM Pivotal Receives Notice of Allowance for U.S. Application 14/594,095 for the Stabilization of Vulnerable Plaque Utilizing a Combination of Statin and PVT-100 - TheNewsWire
Mon, Sep 28, 2015
11:35 AM Pivotal Therapeutics Announces Payment Of Interest On Outstanding Convertible Notes - TheNewsWire
Tue, Sep 22, 2015
7:00 AM Pivotal Therapeutics Announces Issuance of U.S. Patent 9,119,826 for a Kit that Includes Vascazen(tm) and an Omega-3 Fatty Acid Diagnostic Asssay for the Dietary Management of Cardiovascular Patients Deficient in Omega-3 - TheNewsWire
Fri, Aug 28, 2015
9:52 PM Pivotal Therapeutics Announces Second Quarter Financial Results - TheNewsWire
Mon, Jun 29, 2015
8:43 PM Pivotal Therapeutics Announces Proposed Private Placement - TheNewsWire
Thu, Jun 18, 2015
5:53 PM Pivotal Therapeutics Announces Payment of Interest on Outstanding Convertible Notes - Canada Newswire
Thu, Jun 04, 2015
2:25 PM First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100 - Canada Newswire
Mon, Jun 01, 2015
9:19 PM Pivotal Therapeutics Announces First Quarter Financial Results - Canada Newswire
Mon, May 11, 2015
3:17 PM Pivotal Therapeutics Inc. is to be Featured on CEO Clips on CBC's The Documentary Channel - Canada Newswire
Thu, Apr 30, 2015
9:20 PM Pivotal Therapeutics Announces 2014 Financial Results - Canada Newswire
More News for PVO:CNX >>

Tags for Pivotal Therapeutics Inc.

Research stocks or mutual funds related to Pivotal Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to PVO:CNX. The keywords below have been associated to PVO:CNX by either user submission or electronic means.